What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Gene
- Antibiotics
Amy E. Bryant focuses on Microbiology, Gas gangrene, Immunology, Exotoxin and Necrosis.
Her research integrates issues of Immune system and In vivo in her study of Microbiology.
Her research in In vivo intersects with topics in Penicillin and In vitro.
Her work in Gas gangrene tackles topics such as Fulminant which are related to areas like Intensive care, Antibiotic coverage, Antibiotic prophylaxis, Amputation and Intensive care medicine.
Her Immunology study combines topics in areas such as Group A and Toxic shock syndrome.
She interconnects Panton–Valentine leukocidin, Methicillin-resistant Staphylococcus aureus, Leukocidin and Toxic shock syndrome toxin in the investigation of issues within Clindamycin.
Her most cited work include:
- Impact of Antibiotics on Expression of Virulence-Associated Exotoxin Genes in Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureus (371 citations)
- VIRULENCE STUDIES ON CHROMOSOMAL ALPHA -TOXIN AND THETA -TOXIN MUTANTS CONSTRUCTED BY ALLELIC EXCHANGE PROVIDE GENETIC EVIDENCE FOR THE ESSENTIAL ROLE OF ALPHA -TOXIN IN CLOSTRIDIUM PERFRINGENS-MEDIATED GAS GANGRENE (267 citations)
- Necrotizing Soft-Tissue Infections (181 citations)
What are the main themes of her work throughout her whole career to date?
The scientist’s investigation covers issues in Microbiology, Immunology, Gas gangrene, Streptococcus pyogenes and Antibiotics.
The various areas that Amy E. Bryant examines in her Microbiology study include Vancomycin and Methicillin-resistant Staphylococcus aureus.
The study incorporates disciplines such as Group A, Toxic shock syndrome and Pathology in addition to Immunology.
She has included themes like Necrosis, Clostridium septicum, In vivo and Intensive care medicine in her Gas gangrene study.
Her Streptococcus pyogenes research includes themes of Scarlet fever, Fasciitis, Locus and Pathogenesis.
The Antibiotics study combines topics in areas such as Gastroenterology, Internal medicine and Linezolid.
She most often published in these fields:
- Microbiology (73.33%)
- Immunology (45.83%)
- Gas gangrene (27.50%)
What were the highlights of her more recent work (between 2013-2021)?
- Microbiology (73.33%)
- Vancomycin (16.67%)
- Antibiotics (27.50%)
In recent papers she was focusing on the following fields of study:
Amy E. Bryant spends much of her time researching Microbiology, Vancomycin, Antibiotics, Streptococcus pyogenes and Fasciitis.
As a member of one scientific family, Amy E. Bryant mostly works in the field of Microbiology, focusing on Methicillin-resistant Staphylococcus aureus and, on occasion, Extracellular.
Her work carried out in the field of Vancomycin brings together such families of science as Clostridium difficile toxin A, Clostridium difficile, Exotoxin and Staphylococcal infections.
Her work focuses on many connections between Streptococcus pyogenes and other disciplines, such as Scarlet fever, that overlap with her field of interest in Erysipelas, Bacteremia and Superantigen.
Her Fasciitis research incorporates themes from Myositis, Dermatology, Immunology, Soft tissue and Necrosis.
Her studies in Immunology integrate themes in fields like Disease and Edema.
Between 2013 and 2021, her most popular works were:
- Necrotizing Soft-Tissue Infections (181 citations)
- Tigecycline suppresses toxin A and B production and sporulation in Clostridium difficile (31 citations)
- Tigecycline suppresses toxin A and B production and sporulation in Clostridium difficile (31 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Antibiotics
Her primary scientific interests are in Fasciitis, Antibiotics, Streptococcus pyogenes, Immunology and Vancomycin.
She works mostly in the field of Streptococcus pyogenes, limiting it down to topics relating to Scarlet fever and, in certain cases, Superantigen, Pathogenesis, Pneumonia, Bacteremia and Myositis.
Her Immunology research is multidisciplinary, incorporating elements of Gastroenterology and Clindamycin.
Her Vancomycin research is multidisciplinary, incorporating perspectives in Clostridium difficile, Clostridium difficile toxin B, Clostridium difficile toxin A, Microbiology and Tigecycline.
Her research brings together the fields of Virology and Microbiology.
Her research investigates the link between Dermatology and topics such as Clostridium septicum that cross with problems in Gas gangrene.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
